Question 1

How many shares of GANX does MARSHALL WACE, LLP own?

Accepted Answer

As of 2026-Q2, MARSHALL WACE, LLP holds 1.9M shares of GANX (GAIN THERAPEUTICS INC).

Question 2

What is MARSHALL WACE, LLP's GANX position worth?

Accepted Answer

As of 2026-Q2, MARSHALL WACE, LLP's GANX position is worth $3.9M.

Question 3

Is MARSHALL WACE, LLP buying or selling GANX?

Accepted Answer

In 2026-Q2, MARSHALL WACE, LLP increased their GANX position (+8.7% change in shares).

Question 4

When did MARSHALL WACE, LLP first buy GANX?

Accepted Answer

Based on available 13F filings, MARSHALL WACE, LLP first reported a position in GANX in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.9M	+8.7%	$3.9M	0.0%	$2.03	29
2026-Q1	Increased	1.8M	+6.5%	$3.4M	0.0%	$2.63	28
2025-Q4	Increased	1.7M	+849.3%	$5.4M	0.0%	$3.05	44
2025-Q3	Decreased	175,107	-36.6%	$309,939	0.0%	$1.81	0
2025-Q2	Increased	276,433	+41.0%	$497,580	0.0%	$1.97	32
2025-Q1	Increased	196,026	+113.7%	$374,410	0.0%	$1.89	38
2024-Q4	New	91,738	-	$198,155	0.0%	$2.18	32

GANX7 quarters

GANX
7 quarters